Christopher McCall Jones1, Grant T Baldwin1, Wilson M Compton1. 1. Christopher McCall Jones is with the Division of Science Policy, Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC. Grant T. Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Atlanta, GA. Wilson M. Compton is with the National Institute on Drug Abuse, National Institutes of Health, Rockville, MD.
Abstract
OBJECTIVES: To assess trends in cocaine overdose deaths and examine the role opioids play in these deaths. METHODS: We used data on drug overdose deaths in the United States from 2000 to 2015 collected in the National Vital Statistics System to calculate annual rates and numbers of cocaine-related overdose deaths overall and deaths both involving and not involving opioids. We assessed statistically significant changes in trends with joinpoint regression. RESULTS: Rates of cocaine-related overdose deaths increased significantly from 1.26 to 2.50 per 100 000 population from 2000 to 2006, declined to 1.35 in 2010, and increased to 2.13 in 2015. Cocaine-related overdose deaths involving opioids increased from 0.37 to 0.91 from 2000 to 2006, declined to 0.57 in 2010, and then increased to 1.36 in 2015. Cocaine-related overdose deaths not involving opioids increased from 0.89 to 1.59 from 2000 to 2006 and then declined to 0.78 in 2015. CONCLUSIONS: Opioids, primarily heroin and synthetic opioids, have been driving the recent increase in cocaine-related overdose deaths. This corresponds to the growing supply and use of heroin and illicitly manufactured fentanyl in the United States.
OBJECTIVES: To assess trends in cocaine overdose deaths and examine the role opioids play in these deaths. METHODS: We used data on drug overdose deaths in the United States from 2000 to 2015 collected in the National Vital Statistics System to calculate annual rates and numbers of cocaine-related overdose deaths overall and deaths both involving and not involving opioids. We assessed statistically significant changes in trends with joinpoint regression. RESULTS: Rates of cocaine-related overdose deaths increased significantly from 1.26 to 2.50 per 100 000 population from 2000 to 2006, declined to 1.35 in 2010, and increased to 2.13 in 2015. Cocaine-related overdose deaths involving opioids increased from 0.37 to 0.91 from 2000 to 2006, declined to 0.57 in 2010, and then increased to 1.36 in 2015. Cocaine-related overdose deaths not involving opioids increased from 0.89 to 1.59 from 2000 to 2006 and then declined to 0.78 in 2015. CONCLUSIONS: Opioids, primarily heroin and synthetic opioids, have been driving the recent increase in cocaine-related overdose deaths. This corresponds to the growing supply and use of heroin and illicitly manufactured fentanyl in the United States.
Authors: Alexis B Peterson; R Matthew Gladden; Chris Delcher; Erica Spies; Amanda Garcia-Williams; Yanning Wang; John Halpin; Jon Zibbell; Carolyn Lullo McCarty; Jolene DeFiore-Hyrmer; Mary DiOrio; Bruce A Goldberger Journal: MMWR Morb Mortal Wkly Rep Date: 2016-08-26 Impact factor: 17.586
Authors: Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-10 Impact factor: 17.586
Authors: William S John; He Zhu; Paolo Mannelli; Geetha A Subramaniam; Robert P Schwartz; Jennifer McNeely; Li-Tzy Wu Journal: Drug Alcohol Depend Date: 2018-11-26 Impact factor: 4.492
Authors: Wilson M Compton; Christopher M Jones; Grant T Baldwin; Frances M Harding; Carlos Blanco; Eric M Wargo Journal: Am J Public Health Date: 2019-06 Impact factor: 9.308
Authors: Elizabeth A Crummy; Elizabeth A Donckels; Britahny M Baskin; Brandon S Bentzley; Susan M Ferguson Journal: Psychopharmacology (Berl) Date: 2019-08-28 Impact factor: 4.530
Authors: Hawre Jalal; Jeanine M Buchanich; Mark S Roberts; Lauren C Balmert; Kun Zhang; Donald S Burke Journal: Science Date: 2018-09-21 Impact factor: 47.728
Authors: Jenna Valleriani; Rebecca Haines-Saah; Rielle Capler; Ricky Bluthenthal; M Eugenia Socias; M J Milloy; Thomas Kerr; Ryan McNeil Journal: Int J Drug Policy Date: 2020-04-11